Adrenocortical carcinoma metabolomic imaging identifies subpopulations with prognostic potential: buff.ly/3EanADC matthiaskroiss Universität München #Metabolism #Oncology

New somatic mutation in Primary Aldosteronism. Zinc transporter 1 (ZnT1) gene SLC30A1. Congratulations Adina Turcu and group. nature.com/articles/s4158…

Tumor production of glucocorticoids suppresses anti-tumor immunity: buff.ly/46hVnqu National Cancer Institute #Immunology #Oncology

Interesting data on L-type calcium blockade in a mouse model of primary aldosteronism and neurologic abnormalities (PASNA Syndrome) - gain of function in Cacna1d. insight.jci.org/articles/view/…

1/6 Delighted to share findings from our latest study showing that the glucocorticoid activating enzyme HSD11B1 plays a previously unrecognised role in androgen activation especially in women. #openaccess here: sciencedirect.com/science/articl… Stellenbosch University @IMSR_UoB MRC Laboratory of Medical Sciences (MRC LMS)

With CARTaGENE data, we show Subclinical PA is linked to worse central BP, PWV, adverse cardiac remodeling and incident hypertension, all independent of BP. Excellent work from Greg Hundemer and co-authors! Anand Vaidya Swapnil Hiremath @[email protected] Manish M Sood MD ahajournals.org/doi/10.1161/CI…

#Catecholamine-induced hypertensive crises: current insights and management thelancet.com/journals/landi… #phaeochromocytomas #paragangliomas #PPGLs

Long-term follow up of patients with elevated aldosterone-to-renin ratio but negative confirmatory test: the progression of primary aldosteronism phenotypes ahajrnls.org/3UvcKlh

Single-Nuclei Analysis Reveals Tumor Heterogeneity of Aldosterone-Producing Adenoma ahajrnls.org/3UyomUo

Efficacy and safety of aldosterone synthase inhibition with and without empagliflozin for chronic kidney disease: a randomised, controlled, phase 2 trial. 🔗 hubs.li/Q02jD8Q60

Online now: Alessandro Prete & Irina Bancos review the pathophysiology, comorbidities and management approaches for mild autonomous #cortisol secretion rdcu.be/dFCQ0 #europeanhormoneday #becausehormonesmatter

Managing Catecholamine Release Syndrome During and Following Lu-177-DOTATATE in High-Risk Pheochromocytoma Patients academic.oup.com/jcemcr/article…

A practical handout for patients to self-titrate non-interfering antihypertensive at home when preparing to test for #PrimaryAldosteronism... as long as they can understand the instructions and have a blood pressure monitor at home. endocrinesociety.org.au/medication-swi…

A new clinical guideline for a common problem, Glucocorticoid-induced adrenal insufficiency European Society of Endocrinology (ESE) Endocrine Society academic.oup.com/jcem/advance-a…

Original Article: Phase 3 Trial of Crinecerfont in Adult Congenital Adrenal Hyperplasia (CAHtalyst) nej.md/4aFpNVD #ASCO24 | ASCO

Checkout new pub by our #adrenal group Prasanna Santhanam Stanley Chen Cardenas Amir H Hamrahian on "Fully-automated CT derived body composition analysis reveals sarcopenia in functioning adrenocortical carcinomas"! pubmed.ncbi.nlm.nih.gov/38806535/

In a new Science study, researchers demonstrate that artemisinins, compounds known for their antimalarial properties, show promise for preventing and treating polycystic ovary syndrome. 📄: scim.ag/7jQ #SciencePerspective: scim.ag/7jP

🆕🚨 Delighted to see this work published in Wiley CTM. We unveiled cellular diversity within the adult human #adrenalgland, identifying new cell populations and key pathways governing #adrenal homeostasis. A thread 🧵 dx.doi.org/10.1002/ctm2.1…

Went into an antique store here in Maryland and found this historic publication on adrenal function from 1949-1950:

That’s a wrap on the 9th International Adrenal Cancer Symposium. So much learning and collaborating. Great time! Great insights from patients. Thank you for sharing! #adrenal #adrenalcancer European Network for the Study of Adrenal Tumours A5_AdrenalAlliance